Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TGFBR3, also known as betaglycan, is a cell-surface proteoglycan that functions as a co-receptor for TGF-beta ligands. It enhances ligand binding to signaling receptors and modulates both Smad-dependent and non-Smad signaling pathways. It plays critical roles in embryonic development, immune regulation, and tissue homeostasis. Loss or dysfunction of TGFBR3 is implicated in cancer progression and metastasis.
Modulates TGF-beta ligand presentation to signaling receptors; Acts as a ligand trap when cleaved; Modulates Smad and non-Smad signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming Growth Factor Beta Receptor 3 (TGFBR3).